APA (7th ed.) Citation

B, d. l. C. C., LD, B., MD, T., M, M., JJ, V., B, I., . . . AE, Z. (2022). EMMPRIN is an emerging protein capable of regulating cancer hallmarks. European review for medical and pharmacological sciences, 26(18), 6700. https://doi.org/10.26355/eurrev_202209_29771

Chicago Style (17th ed.) Citation

B, de la Cruz Concepción, et al. "EMMPRIN Is an Emerging Protein Capable of Regulating Cancer Hallmarks." European Review for Medical and Pharmacological Sciences 26, no. 18 (2022): 6700. https://doi.org/10.26355/eurrev_202209_29771.

MLA (9th ed.) Citation

B, de la Cruz Concepción, et al. "EMMPRIN Is an Emerging Protein Capable of Regulating Cancer Hallmarks." European Review for Medical and Pharmacological Sciences, vol. 26, no. 18, 2022, p. 6700, https://doi.org/10.26355/eurrev_202209_29771.